Antifungal Peptides as Therapeutic Agents

Area of Science:

• Mycology
• Microbiology
• Biotechnology

Background:

• Fungi are increasingly recognized as human pathogens, with rising rates of community-acquired and nosocomial infections.
• Factors such as antibiotic resistance, increased immunodeficiency, and limited therapeutic options drive the need for new antifungal strategies.
• Antifungal peptides (AFPs) are emerging as potent candidates due to their efficacy and selectivity.

Purpose of the Study:

• To review the bioactivity, classification, and mechanisms of action of antifungal peptides (AFPs).
• To compare the advantages of AFPs over current antifungal drugs.
• To discuss the production and applications of AFPs in combating fungal infections.

Main Methods:

• Literature review of scientific articles on antifungal peptides.
• Analysis of AFP classification, bioactivity, and mechanisms of action.
• Evaluation of current and potential applications and future challenges of AFPs.

Main Results:

• AFPs exhibit high efficacy and selectivity against pathogenic fungi.
• They offer advantages over conventional antifungals, including reduced host toxicity and novel mechanisms of action.
• Various production methods (natural, heterologous, synthetic) are available for AFPs.

Conclusions:

• Antifungal peptides represent a promising alternative to current antifungal therapies.
• Further research and development are needed to overcome challenges in AFP production and application.
• AFPs hold significant potential for future antifungal treatments and the bioeconomy.